[Changing epidemiological profile and treatment of syphilis and gonorrhea].
Reunala
Timo
T
Tampereen yliopisto, lääketieteen laitos ja TAYS:n iho- ja sukupuolitautien klinikka PL 2000 33521 Tampere. timo.reunala@uta.fi
Hiltunen-Back
Eija
E
D000890:Anti-Infective Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D016358:Contact Tracing / Q000331:legislation & jurisprudence; D024881:Drug Resistance, Bacterial; D005260:Female; D005387:Finland / Q000453:epidemiology; D006069:Gonorrhea / Q000188:drug therapy* / Q000453:epidemiology* / Q000635:transmission; D006801:Humans; D010402:Penicillin G Procaine / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000453:epidemiology*; D013587:Syphilis / Q000188:drug therapy* / Q000453:epidemiology* / Q000635:transmission
D000890:Anti-Infective Agents; D002511:Cephalosporins; D010402:Penicillin G Procaine; D002939:Ciprofloxacin; D002443:Ceftriaxone